What is HC Wainwright’s Estimate for CLDX Q1 Earnings?
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) – HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Celldex Therapeutics in a research report issued on Friday, February 28th. HC Wainwright analyst J. Pantginis expects that the biopharmaceutical company will earn ($0.73) per share for the quarter. HC Wainwright currently has a “Buy” […]
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) – HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Celldex Therapeutics in a research report issued on Friday, February 28th. HC Wainwright analyst J. Pantginis expects that the biopharmaceutical company will earn ($0.73) per share for the quarter. HC Wainwright currently has a “Buy” […]
